Wei-Ting Hwang

28PUBLICATIONS
249CO-AUTHORS
Predictive and prognostic markersHuman impacts of climate change and human adaptationRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 22, 2026
A fluorescent choline kinase alpha inhibitor for intraoperative molecular imaging during resection of canine NSCLC tumors.

|Jun 08, 2026
Pediatric Risk Mapping From Co-Exposure to Extreme Temperatures and Air Pollutants.

|Jul 09, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Jun 01, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Stephen J Bagley, Arati S Desai, Joseph A Fraietta

|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall

|Dec 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.

Peter A Riedell, Connor B Grady, Loretta J Nastoupil

Pageof 5

Frequent Collaborators

8 joint publications

Carl H June

8 joint publications

Donald L Siegel

7 joint publications

Elizabeth O Hexner

5 joint publications

Fang Chen